133 related articles for article (PubMed ID: 34912415)
1. Clinical efficacy of immunotherapy combined with chemotherapy in patients with advanced gastric cancer, its effect on nutritional status and Changes of peripheral blood T lymphocyte subsets.
Li WW; Jiao J; Wang ZY; Wei YN; Zhang YF
Pak J Med Sci; 2021; 37(7):1902-1907. PubMed ID: 34912415
[TBL] [Abstract][Full Text] [Related]
2. Clinical effects of Chemotherapy combined with Immunotherapy in patients with advanced NSCLC and the effect on their nutritional status and immune function.
Jiao J; Li WW; Shang YH; Li XF; Jiao M
Pak J Med Sci; 2023; 39(2):404-408. PubMed ID: 36950407
[TBL] [Abstract][Full Text] [Related]
3. Association of lymphocyte subsets with the efficacy and prognosis of PD‑1 inhibitor therapy in advanced gastric cancer: results from a monocentric retrospective study.
Wang X; Liu X; Dai H; Jia J
BMC Gastroenterol; 2024 Mar; 24(1):113. PubMed ID: 38491354
[TBL] [Abstract][Full Text] [Related]
4. Clinical curative effect of neoadjuvant chemotherapy combined with immunotherapy and its impact on immunological function and the expression of ER, PR, HER-2 & SATB1 in HER-2-Positive breast cancer patients.
Chen Z; Sang MX; Geng CZ; Hao W; Jia HQ
Pak J Med Sci; 2022; 38(3Part-I):553-559. PubMed ID: 35480523
[TBL] [Abstract][Full Text] [Related]
5. [Effect of Pembrolizumab on T Lymphocyte Subsets in Patients with Advanced
Non-small Cell Lung Cancer and Its Therapeutic Effect].
Wang Y; Wang Y; Jiang M; Zhao Y; Zhang X
Zhongguo Fei Ai Za Zhi; 2021 Mar; 24(3):182-187. PubMed ID: 33819968
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of highly agglutinative staphylococcin combined with neoadjuvant chemotherapy on patients with intermediate or advanced oral cancer.
Guo N; Lin G; Shi X
Pak J Med Sci; 2022; 38(7):1973-1979. PubMed ID: 36246715
[TBL] [Abstract][Full Text] [Related]
7. [Effect of neoadjuvant chemotherapy on nutritional status of locally advanced gastric cancer].
Deng G; Qu J; Zhai S; Shi Y; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Mar; 21(3):331-335. PubMed ID: 29577223
[TBL] [Abstract][Full Text] [Related]
8. Effect of Intensity Modulated Radiotherapy (IMRT) on the immunity, physical status and clinical effect of locally advanced NSCLC patients.
Xu JK
Pak J Med Sci; 2021; 37(5):1480-1485. PubMed ID: 34475934
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of T lymphocyte subset changes after first line chemotherapy in peripheral blood from patients with advanced stage adenocarcinoma cell lung cancer].
Yan X; Zhao X; Jiao S; Sun S; Wu L; Wu Z
Zhongguo Fei Ai Za Zhi; 2012 Mar; 15(3):164-71. PubMed ID: 22429580
[TBL] [Abstract][Full Text] [Related]
10. Effect of Sintilimab combined with Chemotherapy on Tumor Markers and Immune Function of advanced non-small cell lung cancer.
Liang X; Wei Z
Pak J Med Sci; 2021; 37(4):1063-1068. PubMed ID: 34290784
[TBL] [Abstract][Full Text] [Related]
11. Imbalance of circulating T-lymphocyte subpopulation in gastric cancer patients correlated with performance status.
Wang L; Shen Y
Clin Lab; 2013; 59(3-4):429-33. PubMed ID: 23724636
[TBL] [Abstract][Full Text] [Related]
12. Aberrant Alteration of Circulating Lymphocyte Subsets in Small Cell Lung Cancer Patients Treated with Radiotherapy.
Li H; Yu H; Lan S; Zhao D; Liu Y; Cheng Y
Technol Cancer Res Treat; 2021; 20():15330338211039948. PubMed ID: 34851203
[No Abstract] [Full Text] [Related]
13. Effect of glutamine-enriched nutritional support on intestinal mucosal barrier function, MMP-2, MMP-9 and immune function in patients with advanced gastric cancer during perioperative chemotherapy.
Wang J; Li Y; Qi Y
Oncol Lett; 2017 Sep; 14(3):3606-3610. PubMed ID: 28927119
[TBL] [Abstract][Full Text] [Related]
14. [Changes of T Lymphocyte Subsets and Immunoglobulin in Peripheral Blood of Patients with ALL and N-ALL before and after Treatment and their Value for Monitoring of Disease and Evaluation of Prognosis].
Zhu QY; Dian ZJ; Zhou YG; Zhao Z; Zhang Z; Zhang XY; Yang BR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):136-140. PubMed ID: 29397832
[TBL] [Abstract][Full Text] [Related]
15. [Association of traumatic severity with change in lymphocyte subsets in the early stage after trauma].
Hua R; Chen FX; Zhang YM; Zhou ZH; Wang SJ; Liang J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Aug; 25(8):489-92. PubMed ID: 24021046
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory effect of DC/CIK combined with chemotherapy in multiple myeloma and the clinical efficacy.
Zhao X; Ji CY; Liu GQ; Ma DX; Ding HF; Xu M; Xing J
Int J Clin Exp Pathol; 2015; 8(10):13146-55. PubMed ID: 26722513
[TBL] [Abstract][Full Text] [Related]
17. Impact of the immune cell population in peripheral blood on response and survival in patients receiving neoadjuvant chemotherapy for advanced gastric cancer.
He Q; Li G; Ji X; Ma L; Wang X; Li Y; Fan C
Tumour Biol; 2017 May; 39(5):1010428317697571. PubMed ID: 28475005
[TBL] [Abstract][Full Text] [Related]
18. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
[No Abstract] [Full Text] [Related]
19. Peripheral T lymphocyte immunity and l-dopamine in patients with Parkinson's disease.
Hu ZX; Song WN; Lu XD; Zhou ML; Shao JH
J Biol Regul Homeost Agents; 2018; 32(3):687-691. PubMed ID: 29921400
[TBL] [Abstract][Full Text] [Related]
20. [Changes of lymphocyte subsets before and after chemotherapy in colorectal carcinoma patients].
Zhang GQ; Zhao H; Wen XY; Li JY; Wu LL; Jiao SC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):155-60. PubMed ID: 23643003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
